Antimicrobial ResistanceNews - Page 2

Researchers discover breakthrough in the fight against VRE infections

Researchers have discovered a promising new compound, V-161, which effectively inhibits the growth of VRE infections.

From wastewater to wound care: How phages are found, harvested, and used

Discover how bacteriophages are sourced, refined, and used in cutting-edge treatments to combat infections and AMR.

How phage therapy can combat the global AMR crisis

Discover how phage therapy offers a revolutionary, targeted solution to combat the global antimicrobial resistance crisis.

How AI platforms can help us understand ABR and the POSTABR® era

Richard Stead, CEO of The Qures Group, discusses how different AI platforms can help us define different eras of antimicrobial resistance.

Dogs identified as spreaders of antimicrobial-resistant Salmonella

Discover more about the spread of and approaches needed to combat antimicrobial-resistant Salmonella in household dogs.

Global phage therapy market to reach $116m by 2028 amid rising AMR

Discover how the phage therapy market, valued at $116.6m by 2028, is revolutionising healthcare by addressing antibiotic resistance.

How the Global AMR Innovation Fund is leading the fight against antimicrobial resistance

Discover how the Global AMR Innovation Fund is combating antimicrobial resistance through innovation, global partnerships, and solutions.

Exeter launches second round of funding to tackle antifungal drug resistance

The FAILSAFE project is a groundbreaking initiative tackling antifungal drug resistance. Learn more about the project here.

Antibiotic resistance: 100 years of history

QURES Group offers a nature-inspired approach to effectively combat antibiotic resistance. Find out more now.

Tackling the global threat of antimicrobial resistance

The World Health Organization details the issue of antimicrobial resistance and sets out the actions that need to be taken to reduce this.

The rise of antimicrobial resistance: A global health crisis in the making

Industry can fight against this global health crisis by learning more about risks and solutions and adjusting their business practices.

Bacteriophage therapy offers hope for drug-resistant infections

Qeen Biotechnologies has provided bacteriophage therapy to treat a periprosthetic joint infection caused by an AMR pathogen. Find out more.

Tackling the urgent issue of antibiotic-resistant bacteria

Nathan Stasko, CEO of Vast Therapeutics, discusses how new treatment options like ALX1 can fight against antibiotic-resistant bacteria.

A One Health approach to tackling antimicrobial resistance in animals

Dr Morgan Jeannin from the World Organisation for Animal Health details the actions we can take towards tackling antimicrobial resistance in animals.

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd